Search Results - "Gecse, Krisztina Barbara"

Viscoelastic properties of small bowel mesentery at MR elastography in Crohn’s disease: a prospective cross-sectional exploratory study by van Schelt, Anne-Sophie, Beek, Kim Johanna, Wassenaar, Nienke Petronella Maria, Schrauben, Eric M., Runge, Jurgen H., Gecse, Krisztina Barbara, van der Bilt, Jarmila D. W., Neefjes-Borst, E. Andra, Buskens, Christianne Johanna, Nederveen, Aart J., Stoker, Jaap

“…Background Creeping fat is a pathological feature of small bowel Crohn’s disease (CD), with literature suggesting that bowel resection with extended mesenteric…”
Get full text

Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies by Gonczi, Lorant, Kurti, Zsuzsanna, Golovics, Petra Anna, Lovasz, Barbara Dorottya, Menyhart, Orsolya, Seres, Anna, Sumegi, Liza Dalma, Gal, Alexander, Ilias, Akos, Janos, Papp, Gecse, Krisztina Barbara, Bessisow, Talat, Afif, Waqqas, Bitton, Alain, Vegh, Zsuzsanna, Lakatos, Peter Laszlo

“…In the management of inflammatory bowel diseases, there is considerable variation in quality of care. The aim of this study was to evaluate structural,…”
Get full text

Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Important Role? by Gonczi, Lorant, Vegh, Zsuzsanna, Golovics, Petra Anna, Rutka, Mariann, Gecse, Krisztina Barbara, Bor, Renata, Farkas, Klaudia, Szamosi, Tamás, Bene, László, Gasztonyi, Beáta, Kristóf, Tünde, Lakatos, László, Miheller, Pál, Palatka, Károly, Papp, Mária, Patai, Árpád, Salamon, Ágnes, Tóth, Gábor Tamás, Vincze, Áron, Biro, Edina, Lovasz, Barbara Dorottya, Kurti, Zsuzsanna, Szepes, Zoltan, Molnár, Tamás, Lakatos, Péter L.

“…Abstract Background and Aims: Biosimilar infliximab CT-P13 received European Medicines Agency [EMA] approval in June 2013 for all indications of the originator…”
Get full text

Low incidence of venous thromboembolism in inflammatory bowel diseases: prevalence and predictors from a population-based inception cohort by Vegh, Zsuzsanna, Golovics, Petra Anna, Lovasz, Barbara Dorottya, Kurti, Zsuzsanna, Gecse, Krisztina Barbara, Szita, Istvan, Balogh, Mihaly, Pandur, Tunde, Lakatos, Laszlo, Lakatos, Peter Laszlo

“…AbstractObjective. Patients with inflammatory bowel diseases (IBD) are considered to have an increased risk for venous thromboembolism (VTE). The aim of the…”
Get full text

Optimizing biological therapy in Crohn's disease by Gecse, Krisztina Barbara, Végh, Zsuzsanna, Lakatos, Péter László

“…Anti-TNF therapy has revolutionized the treatment of inflammatory bowel diseases, including both Crohn's disease and ulcerative colitis. However, a significant…”
Get more information

Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease by Kurti, Zsuzsanna, Lovasz, Barbara Dorottya, Gecse, Krisztina Barbara, Balint, Anita, Farkas, Klaudia, Morocza-Szabo, Agnes, Gyurcsanyi, Andras, Kristof, Katalin, Vegh, Zsuzsanna, Gonczi, Lorant, Kiss, Lajos Sandor, Golovics, Petra Anna, Lakatos, Laszlo, Molnar, Tamas, Lakatos, Peter Laszlo

“…There are few data available on the effect of immunomodulator/biological therapy on the accuracy of the tuberculin skin test (TST) and interferon-gamma release…”
Get full text